Continuing Education Information

Target Audience

This activity is intended for health care professionals engaged in the care of pediatric and adult patients with growth disorders.

Educational Objectives

After completing this activity, the participant should be better able to:
  • Initiate and stimulate exchange of ideas for basic and human GH & IGR research
  • Recognize and promote collaboration of clinical studies and basic research
  • Evaluate and accurately diagnose adult growth disorders based on current evidence-based practice guidelines
  • Select optimal guideline-supported therapy in endocrine care of patients with growth disorders
  • Discuss the current status of relevant hormone assays and the mechanisms of action and new analogs of these hormones
  • Assess guidelines for GH and IGF-1 treatment in children and adolescents

Faculty

  • Jesús Argente MD, PhD. Professor, Department of Pediatrics, Universidad Autónoma de Madrid Hospital Infantil Universitario Niño Jesús, Madrid, Spain
  • Julia F. Charles, MD, PhD. Assistant Professor, Department of Orthopedics and Medicine, Brigham and Women’s Hospital, Harvard Medical School
  • Peter Clayton, MD. Professor of Child Health and Pediatric, Division of Developmental Biology & Medicine, University of Manchester
  • Stuart J. Frank, MD. Professor and Director, UAB Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham and Birmingham VA Medical Center
  • Pam Freda, MD. Associate Professor of Medicine, NewYork-Presbyterian Hospital, College of Physicians and Surgeons, Columbia University
  • Andrea Giustina, MD. Professor of Endocrinology, University of Brescia
  • Leroy E. Hood, MD, PhD. Chief Strategy Officer, Co-founder and Professor, Institute for Systems Biology Seattle, WA
  • C. Ronald Kahn, MD. Chief Academic Officer, Joslin Diabetes Center, and the Mary K. Iacocca Professor of Medicine, Harvard Medical School
  • Shlomo Melmed, MD. Executive Vice President, Academic Affairs, and Dean of the Medical Faculty, Cedars-Sinai Medical Center
  • Irène Netchine, MD, PhD. Professor, Hôpital Armand Trousseau, Sorbonne University, INSERM UMRs 938, CRSA, Paris, France
  • Vishwajeet Puri, PhD. Associate Professor, Department of Biomedical Sciences and Diabetes Institute, Ohio University
  • Terry J. Smith, MD. Frederick G.L. Huetwell Professor, Department of Ophthalmology and Visual Sciences, University of Michigan
  • Christian Strasburger, MD. Professor of Medicine and Chief of Clinical Endocrinology, Department of Medicine of Charite-Universitätsmedizin, Campus Mitte, Berlin, Germany
  • Shin-Ichiro Takahashi, PhD. Associate Professor, Graduate School of Agriculture and Life Sciences, The University of Tokyo
  • Nicholas A. Tritos, MD,DSc. Associate Professor of Medicine, Harvard Medical School, Faculty member in the Neuroendocrine Unit, Massachusetts General Hospital
  • Daniela Tropea, PhD. Assistant Professor, Trinity College Dublin

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and the Growth Hormone Research Society. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 9.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 9 contact hours.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Americans with Disabilities Act
(required for live meetings only)

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Bernadette Witty prior to the live event at (206) 949-1333.